MX9703429A - Composiciones hermorroidales y metodos de uso. - Google Patents

Composiciones hermorroidales y metodos de uso.

Info

Publication number
MX9703429A
MX9703429A MX9703429A MX9703429A MX9703429A MX 9703429 A MX9703429 A MX 9703429A MX 9703429 A MX9703429 A MX 9703429A MX 9703429 A MX9703429 A MX 9703429A MX 9703429 A MX9703429 A MX 9703429A
Authority
MX
Mexico
Prior art keywords
percent
weight
amount
total composition
anorectal
Prior art date
Application number
MX9703429A
Other languages
English (en)
Inventor
Amparo Blanco
Original Assignee
Whitehall Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10764101&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9703429(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Whitehall Lab Ltd filed Critical Whitehall Lab Ltd
Publication of MX9703429A publication Critical patent/MX9703429A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Abstract

Esta invencion se refiere a una composicion de gel acuosa para tratar las hemorroides y/o desordenes anorrectales en un ser humano, por la administracion intrarrectalmente y/o a la region anorrectal, la cual contiene uno o más fármacos efectivos en el tratamiento de las hemorroides y un portador que comprende un derivado de celulosa soluble en agua como el agente gelificante en una cantidad desde aproximadamente 0.2% hasta aproximadamente 10% en peso de la composicion total, propilenglicol en una cantidad desde aproximadamente 5% hasta aproximadamente 45% en peso de la composicion total y agua en una cantidad de hasta aproximadamente 94% en peso de la composicion total.
MX9703429A 1994-11-09 1997-05-09 Composiciones hermorroidales y metodos de uso. MX9703429A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9422571A GB9422571D0 (en) 1994-11-09 1994-11-09 Haemorrihoidal compositions and method of use

Publications (1)

Publication Number Publication Date
MX9703429A true MX9703429A (es) 1998-07-31

Family

ID=10764101

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703429A MX9703429A (es) 1994-11-09 1997-05-09 Composiciones hermorroidales y metodos de uso.

Country Status (31)

Country Link
US (3) US6565850B2 (es)
EP (1) EP0785770B1 (es)
JP (1) JP4555402B2 (es)
KR (1) KR100385247B1 (es)
CN (1) CN1101181C (es)
AR (1) AR002944A1 (es)
AT (1) ATE197122T1 (es)
AU (1) AU715566B2 (es)
BR (1) BR9509710A (es)
CA (1) CA2204769C (es)
CZ (1) CZ292100B6 (es)
DE (1) DE69519235T2 (es)
DK (1) DK0785770T3 (es)
ES (1) ES2151968T3 (es)
FI (1) FI119498B (es)
GB (1) GB9422571D0 (es)
GR (1) GR3034784T3 (es)
HK (1) HK1008187A1 (es)
HU (1) HU221480B (es)
IL (1) IL115891A (es)
MX (1) MX9703429A (es)
NO (1) NO319253B1 (es)
NZ (1) NZ295211A (es)
PL (1) PL182403B1 (es)
PT (1) PT785770E (es)
RO (1) RO116766B1 (es)
RU (1) RU2159119C2 (es)
SK (1) SK283421B6 (es)
TW (1) TW501932B (es)
WO (1) WO1996014828A1 (es)
ZA (1) ZA959438B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422571D0 (en) * 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
DK0946155T4 (da) 1996-12-23 2009-05-11 Sla Pharma Ag Farmaceutisk sammensætning til behandling af fækal inkontinens
FR2779061B1 (fr) * 1998-04-14 2004-08-20 Pharmatop Nouveau procede de stabilisation de composes phenoliques et les compositions pharmaceutiques en resultant
JP4473539B2 (ja) * 2003-08-12 2010-06-02 エスエス製薬株式会社 医薬組成物
EP1682012A4 (en) * 2003-11-13 2008-09-24 Alza Corp COMPOSITION AND APPARATUS FOR TRANSDERMAL DELIVERY
US20050107867A1 (en) * 2003-11-17 2005-05-19 Taheri Syde A. Temporary absorbable venous occlusive stent and superficial vein treatment method
US20060004094A1 (en) 2004-07-02 2006-01-05 Agisim Gary R Composition and method for treating hemorrhoids and/or anorectal disorders
US20060075522A1 (en) * 2004-07-31 2006-04-06 Jaclyn Cleveland Genes and uses for plant improvement
US20060052822A1 (en) * 2004-08-31 2006-03-09 Mirizzi Michael S Apparatus and material composition for permanent occlusion of a hollow anatomical structure
US7972354B2 (en) 2005-01-25 2011-07-05 Tyco Healthcare Group Lp Method and apparatus for impeding migration of an implanted occlusive structure
CN103948927B (zh) 2005-06-17 2017-11-07 威斯康星校友研究基金会 在癌症化疗和放疗时保护细胞的局部血管收缩剂制品和方法
AU2012202731B2 (en) * 2005-06-17 2014-06-19 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
AU2014202738B2 (en) * 2005-06-17 2016-05-12 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
AU2016202290B2 (en) * 2005-06-17 2017-10-05 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
US9017361B2 (en) 2006-04-20 2015-04-28 Covidien Lp Occlusive implant and methods for hollow anatomical structure
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
JP5369389B2 (ja) * 2006-05-25 2013-12-18 大正製薬株式会社 痔疾治療用組成物
US9005652B2 (en) 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
CN101152166B (zh) * 2007-09-06 2010-12-08 武汉大学 一种治疗痔病的异甘草素凝胶剂及制备方法
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
JP5757861B2 (ja) 2008-04-24 2015-08-05 メドトロニック，インコーポレイテッド キトサン−含有保護用組成物
JP2011518837A (ja) 2008-04-24 2011-06-30 メドトロニック，インコーポレイテッド 再水和可能なチオール化多糖粒子およびスポンジ
EP2310002B1 (en) 2008-04-24 2016-11-02 Medtronic, Inc Protective gel based on chitosan and oxidized polysaccharide
JP5653342B2 (ja) * 2008-04-24 2015-01-14 メドトロニック，インコーポレイテッド 冷間電離放射線滅菌
US20090297643A1 (en) * 2008-06-02 2009-12-03 Micro-Dose Life Sciences, Llc Botanical composition and its uses
US9545391B2 (en) * 2010-08-11 2017-01-17 Hemaway Llc Medicated ointment for treating hemorrhoid and method of using the same
ITMI20111732A1 (it) * 2011-09-27 2013-03-28 Bsdpharma Srl Formulazioni farmaceutiche per la riduzione della sensibilizzazione crociata tra colon-retto ed il distretto urogenitale con mezzi non-farmacologici.
JP5697573B2 (ja) * 2011-10-14 2015-04-08 大正製薬株式会社 清涼化剤含有ゲル状痔疾治療用剤
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
CN103919952A (zh) * 2014-04-21 2014-07-16 张维芬 一种治疗痔疮的凝胶剂及其制备方法
CN104173344A (zh) * 2014-09-18 2014-12-03 杨传爱 一种治疗无痛注射痔疮的新疗法
US10039830B2 (en) * 2016-03-04 2018-08-07 Cetylite Industries, Inc. Topical anesthetic composition
BR102018008324A2 (pt) * 2018-04-25 2019-11-05 Laboratorios Ferring Ltda composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico
US11576801B2 (en) 2019-01-24 2023-02-14 Robert S. Cutler Topical treatment for anorectal disorders with and without seat cushion
FR3108841B1 (fr) * 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline
IT202000010924A1 (it) * 2020-05-13 2021-11-13 Neilos S R L “composizione per la prevenzione e il trattamento di patologie dell’apparato circolatorio e dei sintomi correlati”

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US420763A (en) * 1890-02-04 Art of manufacturing articles from wood pulp
US429987A (en) * 1890-06-10 Whip-rack
US462800A (en) * 1891-11-10 Pipe punch and cutter
US384522A (en) * 1888-06-12 Snow-plow
US631783A (en) * 1899-04-18 1899-08-29 Reversible Collar Company Attachment for calendering-machines.
US797324A (en) * 1903-12-10 1905-08-15 Johnspratt Company Safety-fuse.
GB1261881A (en) 1967-12-04 1972-01-26 Ethichem Ltd Improvements in or relating to pharmaceutical compositions comprising witch hazel
US3839552A (en) * 1969-06-02 1974-10-01 C Kosti Composition for the treatment of hypertrophied oral tissue
US3987163A (en) * 1973-07-27 1976-10-19 Burton, Parsons And Company, Inc. Polystyrene sulfonate containing opthalmic solutions
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
US4192866A (en) * 1978-10-10 1980-03-11 Ralph Anderson Anorectal medication
US4383986A (en) * 1981-08-17 1983-05-17 Ortho Pharmaceutical Corporation Hemorrhoidal compositions
US4604384A (en) 1982-06-24 1986-08-05 Smith Robert A Pharmaceutical gel composition
JPS6121251A (ja) 1984-07-11 1986-01-29 鹿島建設株式会社 プレストレス導入用ｐｃストランド束の挿入方法およびその装置
JPS6228392A (ja) 1985-07-26 1987-02-06 株式会社ブリヂストン 貯槽用通気栓
US4797392A (en) * 1987-01-27 1989-01-10 Chernomorsky Simon A Use of anorectal compositions
GB2229443A (en) * 1989-03-07 1990-09-26 American Cyanamid Co Wound dressings
CA2011423A1 (en) * 1989-03-07 1990-09-07 Peter M. Taylor Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
US5002675A (en) 1989-07-13 1991-03-26 Randisi Sal A Cable pulling compounds
GB9422571D0 (en) * 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
US5880076A (en) * 1997-08-04 1999-03-09 Lever Brothers Company, Division Of Conopco, Inc. Compositions comprising glycacarbamate and glycaurea compounds

Also Published As

Publication number Publication date
CZ139297A3 (en) 1997-12-17
GR3034784T3 (en) 2001-02-28
NO319253B1 (no) 2005-07-04
HUT77359A (hu) 1998-03-30
HU221480B (en) 2002-10-28
JP4555402B2 (ja) 2010-09-29
EP0785770B1 (en) 2000-10-25
DE69519235D1 (de) 2000-11-30
FI119498B (fi) 2008-12-15
CN1101181C (zh) 2003-02-12
JPH10508833A (ja) 1998-09-02
DE69519235T2 (de) 2009-09-17
ES2151968T3 (es) 2001-01-16
ZA959438B (en) 1997-05-07
US20070003627A1 (en) 2007-01-04
NO972125L (no) 1997-07-02
CA2204769C (en) 2005-01-25
NO972125D0 (no) 1997-05-07
US20030035850A1 (en) 2003-02-20
DK0785770T3 (da) 2000-11-20
PL320487A1 (en) 1997-09-29
SK58797A3 (en) 1998-09-09
IL115891A (en) 2001-04-30
AU715566B2 (en) 2000-02-03
FI971969A0 (fi) 1997-05-07
NZ295211A (en) 2000-01-28
EP0785770A1 (en) 1997-07-30
HK1008187A1 (en) 1999-05-07
BR9509710A (pt) 1997-09-30
PL182403B1 (en) 2001-12-31
IL115891A0 (en) 1996-01-31
GB9422571D0 (en) 1995-01-04
CA2204769A1 (en) 1996-05-23
TW501932B (en) 2002-09-11
KR100385247B1 (ko) 2003-08-21
AR002944A1 (es) 1998-05-27
US20040037888A1 (en) 2004-02-26
KR970706794A (ko) 1997-12-01
WO1996014828A1 (en) 1996-05-23
PT785770E (pt) 2001-03-30
RU2159119C2 (ru) 2000-11-20
AU3850395A (en) 1996-06-06
FI971969A (fi) 1997-06-30
SK283421B6 (sk) 2003-07-01
ATE197122T1 (de) 2000-11-15
US6565850B2 (en) 2003-05-20
RO116766B1 (ro) 2001-06-29
CZ292100B6 (cs) 2003-07-16
CN1171045A (zh) 1998-01-21

Similar Documents

Publication Publication Date Title
MX9703429A (es) Composiciones hermorroidales y metodos de uso.
RU97109845A (ru) Противогеморройные композиции и способ применения
EE03004B1 (et) Tselluloosi sisaldava teraviljaekstrakti valmistamise meetod
CA2222676A1 (en) New pharmaceutical composition with anaesthetic effect
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
AR005679A1 (es) Composiciones suavizantes de la piel que contienen hidroxiacidos y metodos para su utilizacion.
UA37263C2 (uk) Протруйник та спосіб протруювання насіння
CA2300679A1 (en) Method of reducing intestinal gas, cramping and anorectal irritation
DE3485100D1 (de) Topische antibiotische zusammensetzung zur behandlung der schleimhaeute.
EP0136569A3 (en) Isoflavone derivatives, their production and use
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
YU13599A (sh) Primena farmaceutske kompozicije za dobijanje leka u obliku gela
DE3479728D1 (en) Derivatives of thiophenesulfonamide, their preparation and pharmaceutical composition for the topical treatment of elevated intraocular pressure
SE9403905D0 (sv) New formulations
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
ZA824118B (en) Saturated aminocyclitol derivatives, their preparation and medicaments containing these compounds
CA2071837A1 (en) Vitamin-Mineral Treatment Methods and Compositions
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
ES8307493A1 (es) Procedimiento para preparar una crema grasa terapeutica de rapida absorcion por la piel.
NZ333443A (en) Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient
WO1998011919A3 (en) Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof
MD457G2 (ro) Derivaţi noi de naftiridină, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizarea lor ca medicamente de antireproducere